Mozarc Medical Holding LLC
Mozarc Medical Holding LLC, headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for the healthcare sector. Founded in recent years, the company has quickly established itself as a leader in the development of advanced medical technologies, particularly in the fields of surgical and interventional products. With a focus on enhancing patient outcomes, Mozarc Medical offers a range of unique core products and services designed to improve surgical precision and efficiency. Their commitment to quality and innovation has positioned them favourably in the market, earning recognition for their contributions to medical advancements. As they continue to expand their operational reach, Mozarc Medical remains dedicated to driving progress in healthcare through cutting-edge technology and exceptional service.
DitchCarbon Score
How does Mozarc Medical Holding LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mozarc Medical Holding LLC's score of 38 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mozarc Medical Holding LLC's reported carbon emissions
In 2024, Mozarc Medical Holding LLC reported significant carbon emissions, totalling approximately 3,360,000,000 kg CO2e across all scopes. This includes about 360,803,000 kg CO2e from Scope 1 emissions, approximately 450,611,000 kg CO2e from Scope 2 emissions, and a substantial 2,993,388,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals key contributors such as purchased goods and services (about 1,385,959,000 kg CO2e), employee commute (approximately 192,383,000 kg CO2e), and waste generated in operations (around 155,689,000 kg CO2e). In 2023, the company’s emissions were slightly lower, with Scope 1 emissions at about 387,049,000 kg CO2e and Scope 2 emissions at approximately 470,806,000 kg CO2e. However, no Scope 3 data was disclosed for that year. Despite the substantial emissions figures, Mozarc Medical has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. This lack of formal commitments may reflect broader industry trends where companies are increasingly scrutinised for their environmental impact and climate strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 376,907,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 541,727,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mozarc Medical Holding LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
